Thairath Online
4 May 2022 16:43
ChulalongkornReveals the progress of the Thai nationality of the Covid-19 vaccine. ChulaCov19 The m-RNA type as a whole is good news. Able to produce the first lot of vaccines in Thailand already
On May 4, 2022, Prof. Dr. Kiat Rakrungtham Director of Development Project Managementcovid vaccine-19 Vaccine Research Center Faculty of Medicine, Chulalongkorn
The development is divided into 2 phases, the first phase is the design of the vaccine and the factory in the United States to produce the first lot, there is good news that It has been proven in the volunteers in phases 1 and 2, and found that it is safe, stimulates the immune system to be highly satisfactory. And the size we chose compared to the vaccine that has been approved for use in Thailand, such as Pfizer, was clearly higher.
The second phase is the production of vaccines in the country by Thai factories, namely Bionet Asia Co., Ltd. which was able to produce the first lot of vaccines in Thailand already passed quality assurance The research team then submitted documents and information for consideration by the Food and Drug Administration. To request a test in volunteers in phase 1-2, which is currently pending approval from the FDA. When can we start testing in volunteers? It is expected that the answer will be received soon if the test can be achieved according to the goals set. is expected to askVaccine registrationavailable by the end of 2022
“Now the epidemic situation in the country is getting better and better. But the research team’s vaccine development didn’t stop. Which we would like to see the first generation of vaccines produced by Thai people who are now developing 3 types, namely the Faculty of Medicine vaccine, the Faculty of Medicine vaccine, the Medicine leaf vaccine and the Government Pharmaceutical Organization vaccine. Able to register at least one type or all of them would be better. The first batch of vaccines, according to the procedure, should be registered first. which must be proven to be safe
While requesting for the registration of the first generation vaccine, we are also developing the second generation vaccine to protect against omikron at the same time. to wait for registration in the next order Importantly, Thailand has our own technology. From the invention, design, testing and production in the factory in the country enabling us to be self-reliant If there is a new outbreak of Covid-19, no matter what species Or a new disease outbreak occurs, we will be able to develop a vaccine by ourselves in a faster time. because we can develop the whole chain by ourselves,” said Prof. Dr. Kiat.
Prof. Dr. Kiat said that if Thai vaccines can be registered within this year must rely on all sectors to support each other But vaccine production has to be done step by step. Both have to prove their effectiveness and safety. which is the main objective of Thailand’s vaccine development so that we can be self-reliant as well as helping to distribute vaccines to neighboring countries faster If an epidemic occurs And the fact that we have technology from upstream, midstream to downstream, when an epidemic occurs we will do it faster The process of inventing, designing, manufacturing and testing in human phases 1 and 2 within 6 months, not taking more than a year like now, because at that time our chain was not fully integrated.
Read more…